Protein kinase C does not mediate the inhibitory action of lead on vitamin D3-dependent production of osteocalcin in osteoblastic bone cells

Toxicology and Applied Pharmacology

Volumn 178, Issue 2, 2002, Pages 109-116

  Guity, Partow ^a   McCabe Jr , Michael J ^a   Pitts, David K ^a   Santini, Ronald P ^a   Pounds, Joel G ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Cell signaling; Lead; Lead toxicity; Osteoblasts; Osteocalcin; Protein kinase C; ROS 17 2.8; Vitamin D3

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; COLECALCIFEROL; LEAD; OSTEOCALCIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE C ZETA;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME INHIBITION; LEAD POISONING; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA CELL; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 0037081658     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1999.8819     Document Type: Article

References (34)

1. Longitudinal analysis of prenatal and postnatal lead exposure and early cognitive development
2. Low-level lead exposure, intelligence and academic achievement: A long-term follow-up study
3. The selective protein kinase C inhibitor, Ro-31-8220, inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) expression, induces c-Jun expression, and activates Jun N-terminal kinase
4. Control of 1,25-dihydroxyvitamin D receptor-mediated enhancement of osteocalcin gene transcription: Effects of perturbing phosphorylation pathways by okadaic acid and staurosporine
5. An essential role for autophosphorylation in the association of activated protein kinase C from the plasma membrane
6. 3 receptor is selectively phosphorylated by protein kinase C on serine 51, a residue crucial to its transactivation function
7. 3 receptor by PKC
8. Cleavage of structural proteins during the assembly of the bacteriophage T4
9. Inhibition of astroglia-induced endothelial differentiation by inorganic lead: A role for protein kinase C
10. Lead impairs the production of osteocalcin by rat osteosarcoma (ROS 17/2.8) cells
11. Cellular lead toxicity and metabolism in primary and clonal osteoblastic bone cells
12. 19F-NMR
13. PKC inhibitors eliminate hippocampal long-term potentiation
14. 2+ on expression of acetylcholinesterase and the acetylcholine receptor
15. Parathyroid hormone-responsive clonal cell from ret osteosarcoma
16. Picomolar concentration of lead stimulate brain protein kinase C
17. Lead activates protein kinase C in immature rat brain microvessels
18. Sequential osteocalcin sampling as a biochemical marker of the success of treatment in moderately lead (Pb) poisoned children
19. Selective inhibition of PKC isozymes by the indolocarbazole Gö6976
20. Inhibition of brain protein kinase C subtypes by lead
21. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys
22. Cellular and molecular toxicity of lead in bone
23. A study of the cellular mechanism by which lead affects catecholamine secretion
24. Synaptic plasticity and PKC
25. Lead, blood pressure, and cardiovascular disease in men and women
26. Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro
27. Measurement of protein using bicinchoninic acid
28. 2+ on protein kinase C isozyme
29. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protien kinase C
30. Inhibitory effects of lead on tube formation by cultured human vascular endothelial cells
31. 3 in bone
32. Bidirectional regulation of the 1,25-dihydroxyvitamin D receptor by phorbol ester activated PKC in osteoblast-like cells: Interaction with adenosine 3′,5′-monophosphate-induced up-regulation of the 1,25-dihydroxyvitamin D receptor
33. Evidence for the coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D and parathyroid hormone